OMAHA, Neb. (May 20, 2016) Transgenomic, Inc. (NASDAQ: TBIO), today announced that the company will hold its First Quarter 2016 Financial Results and Business Update Conference Call on May 24, 2016 at 9:00 AM EDT. The company will present an overview of financial results for the first quarter in a press release issued at 7:30 AM EDT that day.

To participate in the call, dial 877-876-9176 from the U.S. and Canada, or 785-424-1667 from international locations, and enter conference ID: TRANS.  The call will be webcast live and can be accessed at, which is also available at the Investor page of Transgenomic’s website.

A replay will be available for two weeks beginning approximately two hours after the call’s conclusion, until 11:59 PM EDT June 6, 2016. To access the replay, dial 800-839-0866 (domestic) or 402-220-0662 (international). The conference call will also be archived at the Investor section of the company’s website.

About Transgenomic, Inc.

Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in oncology and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD-PCR™, which enables use of liquid biopsies for mutation detection. Transgenomic also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies. Transgenomic’s diagnostic technologies are designed to improve medical diagnoses and patient outcomes.



BLL Partners LLC

Barbara Lindheim




Transgenomic Investor Relations